Celliant® and Dream Recovery Join Forces - Jun 16

The Story

Hologenix, LLC, creator of CELLIANT® infrared technology, and Dream Recovery announced a new infrared weighted recovery blanket on Jun 16, 2026, combining deep pressure stimulation with CELLIANT science-backed IR technology to support restful sleep and overnight recovery. The companies said the product aims to convert sleep into active recovery, but neither company provided public ticker information or sales figures in the announcement.

Why It Matters For Your Portfolio

• Launch Date: The product was announced on Jun 16, 2026, marking a clear commercialization milestone that could drive near-term retail activity for both brands.
• Product Differentiation: The blanket pairs deep pressure stimulation with CELLIANT infrared technology, a technical combination that may broaden appeal in the recovery and sleep wellness market.
• Brand Leverage: Hologenix, LLC is identified as the creator of CELLIANT®, which could help Dream Recovery leverage an established technology name to accelerate consumer trust and distribution.
• Data Gap: The announcement did not include revenue guidance, pricing, or distribution details, so impact on top-line figures remains uncertain for investors tracking commercial adoption.

The Trade

Growth and consumer-health investors should watch retail availability and early sales traction, while traders may monitor news flow around distribution or partner deals. Key next items to watch are product launch timing in stores or online, any reported sales figures, and announcements of retail or distribution partnerships that would clarify commercial scale.